SCHEMBL9540100

SCHEMBL9540100

C#CC1(c2ccccc2)c2cc(Cl)ccc2NC(=O)N1C1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 3/20 0.35
CYP46A1 Q9Y6A2 2/20 0.35
AKR1B1 P15121 3/20 0.34
PGR P06401 2/20 0.34
HTR2A P28223 2/20 0.34
NR1I2 O75469 1/20 0.34
NR3C1 P04150 1/20 0.34
ADRB1 P08588 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CNR1 P21554 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2C P28335 1/20 0.34
MAPK1 P28482 1/20 0.34
AGTR1 P30556 1/20 0.34
CCKBR P32239 1/20 0.34
PPARG P37231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9539085 0.95 AKR1C3 (0.36) AKR1C3MEN1KMT2AKDM4EMAPT
SCHEMBL9539767 0.81 AKR1B1 (0.48) AKR1C3MEN1KMT2AMAPTAKR1B1
SCHEMBL9539948 0.80 KDM4E (0.52) AKR1C3MEN1KMT2AKDM4EMAPT
SCHEMBL9542678 0.79 AKR1B1 (0.38) AKR1C3MEN1KMT2AMAPTAKR1B1
SCHEMBL9539751 0.78 AKR1B1 (0.38) AKR1C3MEN1KMT2AMAPTCYP46A1
SCHEMBL9540193 0.75 MEN1 (0.47) AKR1C3MEN1KMT2AKDM4EMAPT
SCHEMBL9540059 0.72 PGR (0.40) AKR1C3MAPTAKR1B1PGR
SCHEMBL9539179 0.71 ADAMTS5 (0.42) MAPTTP53
SCHEMBL9539046 0.71 PGR (0.38) AKR1C3MAPTPGR
SCHEMBL9539809 0.69 PDE7A (0.48) AKR1C3MAPTAKR1B1PGRHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1071917-A Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist MERCK & CO INC (US) 1993-05-12 CN claimed
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP claimed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO claimed
CN-1071917-A Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist MERCK & CO INC (US) 1993-05-12 CN disclosed
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed